FindTrial
Sign In

A study to assess the feasibility and safety of percutaneous transluminal coronary radio frequency treatment of hypertrophic obstructive cardiomyopathy

A study to assess the feasibility and safety of percutaneous transluminal coronary radio frequency treatment of hypertrophic obstructive cardiomyopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066128
Enrollment
Unknown
Registered
2022-11-24
Start date
2022-11-25
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertrophic obstructive cardiomyopathy

Interventions

Treatment group :percutaneous transluminal coronary radio frequency

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study includes patients with hypertrophic obstructive cardiomyopathy and signing the informed consent.

Exclusion criteria

Exclusion criteria: We exclude patients rejecting the informed consent.

Design outcomes

Primary

MeasureTime frame
Immediate success rate;Clinical success rate;—

Countries

China

Contacts

Public ContactQiang Wu

Guizhou Provincial People's Hospital

gzgywq@162.com+86 139 8411 2269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026